|
US7825121B2
(en)
*
|
1999-05-04 |
2010-11-02 |
Schering Corporation |
Piperazine derivatives useful as CCR5 antagonists
|
|
JP4303969B2
(ja)
*
|
2001-03-29 |
2009-07-29 |
シェーリング コーポレイション |
Ｃｃｒ５アンタゴニストとして有用なアリールオキシム−ピペラジン
|
|
AR033452A1
(es)
|
2001-03-29 |
2003-12-17 |
Schering Corp |
Antagonistas de ccr5 utiles para el tratamiento del sida
|
|
EP1451174B1
(en)
*
|
2001-11-29 |
2010-08-18 |
Schering Corporation |
Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
|
|
EP2311818B1
(en)
|
2002-02-28 |
2013-01-16 |
Novartis AG |
Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug
|
|
JP4671091B2
(ja)
*
|
2002-03-18 |
2011-04-13 |
東レ・ファインケミカル株式会社 |
１−置換−２−メチルピペラジンの製造方法
|
|
US6992189B2
(en)
*
|
2002-03-29 |
2006-01-31 |
Schering Corporation |
Synthesis of piperidine and piperazine compounds as CCR5 antagonists
|
|
CN100343240C
(zh)
|
2002-03-29 |
2007-10-17 |
先灵公司 |
手性2－甲基－4－保护的哌嗪的立体选择性烷基化
|
|
US20050245537A1
(en)
*
|
2002-04-24 |
2005-11-03 |
Noboru Tsuchimori |
Use of compounds having ccr antagonism
|
|
JP2003335737A
(ja)
|
2002-05-21 |
2003-11-28 |
Central Glass Co Ltd |
光学活性（ｒ）−１−（４−トリフルオロメチルフェニル）エチルアミン
|
|
TW200504033A
(en)
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
EP1570860A4
(en)
*
|
2002-12-13 |
2009-06-03 |
Ono Pharmaceutical Co |
ANTAGONIST AND AGONIST BINDING TO A STRONG BINDING SITE OF THE CHEMOKINE RECEPTOR
|
|
PE20040769A1
(es)
*
|
2002-12-18 |
2004-11-06 |
Schering Corp |
Derivados de piperidina utiles como antagonisas ccr5
|
|
RU2366655C2
(ru)
|
2003-03-14 |
2009-09-10 |
Оно Фармасьютикал Ко., Лтд. |
Азотсодержащие гетероциклические производные и лекарственные средства, содержащие их в качестве активного ингредиента
|
|
US20070043079A1
(en)
*
|
2003-04-18 |
2007-02-22 |
Hiromu Habashita |
Heterocyclic compound containing nitrogen atom and use thereof
|
|
WO2004092169A1
(ja)
|
2003-04-18 |
2004-10-28 |
Ono Pharmaceutical Co., Ltd. |
スピロピペリジン化合物およびその医薬用途
|
|
AR044519A1
(es)
|
2003-05-02 |
2005-09-14 |
Novartis Ag |
Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
|
|
RU2006100190A
(ru)
*
|
2003-06-13 |
2006-08-10 |
Шеринг Акциенгезельшафт (De) |
Производные хинолиламида в качестве антагонистов ccr-5
|
|
GB0313661D0
(en)
*
|
2003-06-13 |
2003-07-16 |
Avecia Ltd |
Process
|
|
US7345042B2
(en)
|
2003-06-30 |
2008-03-18 |
Schering Corporation |
MCH antagonists for the treatment of obesity
|
|
KR20060100409A
(ko)
|
2003-11-03 |
2006-09-20 |
쉐링 코포레이션 |
케모킨 수용체 억제제로서 유용한 비피페리디닐 유도체
|
|
GB0329284D0
(en)
*
|
2003-12-18 |
2004-01-21 |
Avecia Ltd |
Process
|
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
CA2554465A1
(en)
|
2004-02-05 |
2005-08-25 |
Schering Corporation |
Piperidine derivatives useful as ccr3 antagonists
|
|
RU2006132465A
(ru)
*
|
2004-02-10 |
2008-03-20 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Модуляторы хемокинового рецептора ccr5
|
|
AU2005219788B2
(en)
|
2004-03-05 |
2010-06-03 |
Nissan Chemical Corporation |
Isoxazoline-substituted benzamide compound and noxious organism control agent
|
|
EA015517B1
(ru)
*
|
2004-04-13 |
2011-08-30 |
Инсайт Корпорейшн |
Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора
|
|
ATE382623T1
(de)
|
2004-06-09 |
2008-01-15 |
Hoffmann La Roche |
Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln
|
|
GB0417804D0
(en)
*
|
2004-08-10 |
2004-09-15 |
Novartis Ag |
Organic compounds
|
|
US8143404B2
(en)
*
|
2004-09-13 |
2012-03-27 |
Ono Pharmaceutical Co., Ltd |
Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient
|
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
|
CN102633730A
(zh)
|
2004-12-03 |
2012-08-15 |
先灵公司 |
作为cb1拮抗剂的取代哌嗪
|
|
WO2006071875A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
JP2008526862A
(ja)
|
2005-01-06 |
2008-07-24 |
シェーリング コーポレイション |
ピペラジン化合物の薬学的な塩の調製
|
|
PE20061164A1
(es)
|
2005-02-16 |
2006-10-27 |
Schering Corp |
Piperazin-piperidinas sustituidas con pirazinilo con actividad antagonista de cxcr3
|
|
MX2007010067A
(es)
|
2005-02-16 |
2007-12-07 |
Schering Corp |
Compuestos heterociclicos novedosos sustituidos con piridina o fenilo con actividad antagonista de cxcr3.
|
|
EP1853583B1
(en)
*
|
2005-02-16 |
2011-09-07 |
Schering Corporation |
Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
|
|
JP2008530218A
(ja)
*
|
2005-02-16 |
2008-08-07 |
シェーリング コーポレイション |
Ｃｘｃｒ３アンタゴニスト活性を有する、ピリジルおよびフェニルで置換されたピペラジン−ピペリジン
|
|
MX2007010068A
(es)
*
|
2005-02-16 |
2007-10-10 |
Schering Corp |
Piperazino-piperidinas con actividad antagonista de cxcr3.
|
|
EP1858887A1
(en)
*
|
2005-02-23 |
2007-11-28 |
Schering Corporation |
Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
EP1889622A4
(en)
|
2005-05-31 |
2009-12-23 |
Ono Pharmaceutical Co |
SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
|
|
ES2330788T3
(es)
|
2005-06-02 |
2009-12-15 |
F. Hoffmann-La Roche Ag |
Derivados de piperidin-4-il-amida y su uso como antagonistas del subtipo 5 del receptor sst.
|
|
US7665658B2
(en)
|
2005-06-07 |
2010-02-23 |
First Data Corporation |
Dynamic aggregation of payment transactions
|
|
CN101291905A
(zh)
|
2005-10-19 |
2008-10-22 |
弗·哈夫曼-拉罗切有限公司 |
苯乙酰胺nnrt抑制剂
|
|
WO2007045477A2
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Human antibodies against il-13 and therapeutic uses
|
|
EP2657235A1
(en)
|
2005-10-28 |
2013-10-30 |
Ono Pharmaceutical Co., Ltd. |
Compound containing basic group and use thereof
|
|
WO2007058322A1
(ja)
|
2005-11-18 |
2007-05-24 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
JP2009517474A
(ja)
*
|
2005-11-30 |
2009-04-30 |
シェーリング コーポレイション |
Ｃｃｒ５拮抗剤およびｃｘｃｒ４拮抗剤の組み合わせを含む組成物
|
|
GB0525671D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
JP2009528266A
(ja)
|
2006-01-18 |
2009-08-06 |
シェーリング コーポレイション |
カンナビノイド受容体修飾因子
|
|
JO2660B1
(en)
|
2006-01-20 |
2012-06-17 |
نوفارتيس ايه جي |
Pi-3 inhibitors and methods of use
|
|
CA2644368A1
(en)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
|
PT2322525E
(pt)
|
2006-04-21 |
2013-12-26 |
Novartis Ag |
Derivados de purina para utilização como agonistas do recetor de adenosina a2a
|
|
WO2007132846A1
(ja)
|
2006-05-16 |
2007-11-22 |
Ono Pharmaceutical Co., Ltd. |
保護されていてもよい酸性基を含有する化合物およびその用途
|
|
JP5245827B2
(ja)
|
2006-07-31 |
2013-07-24 |
小野薬品工業株式会社 |
スピロ結合した環状基を含有する化合物およびその用途
|
|
RU2451676C2
(ru)
|
2006-08-16 |
2012-05-27 |
Ф.Хоффманн-Ля Рош Аг |
Ненуклеозидные ингибиторы обратной транскриптазы
|
|
WO2008037477A1
(en)
|
2006-09-29 |
2008-04-03 |
Novartis Ag |
Pyrazolopyrimidines as p13k lipid kinase inhibitors
|
|
MX2009005881A
(es)
|
2006-12-13 |
2009-06-12 |
Hoffmann La Roche |
Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
|
|
GB0625523D0
(en)
*
|
2006-12-21 |
2007-01-31 |
Ge Healthcare Ltd |
In vivo imaging agents
|
|
RS51644B
(sr)
|
2007-01-10 |
2011-10-31 |
Irm Llc. |
Jedinjenja i preparati kao inhibitori kanal aktivirajuće proteaze
|
|
CA2681162C
(en)
|
2007-03-15 |
2015-11-24 |
Novartis Ag |
Benzyl and pyridine derivatives as modulators of hedgehog pathway
|
|
WO2008119663A1
(en)
|
2007-03-29 |
2008-10-09 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
CN101687851B
(zh)
|
2007-05-07 |
2013-02-27 |
诺瓦提斯公司 |
有机化合物
|
|
JP5603770B2
(ja)
|
2007-05-31 |
2014-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｃｒ２受容体拮抗薬およびその使用
|
|
RU2010116821A
(ru)
*
|
2007-10-01 |
2011-11-10 |
Ф.Хоффманн-Ля Аг (Ch) |
N-гетероциклические биарильные карбоксамиды в качестве антагонистов рецептора ccr
|
|
CL2008003651A1
(es)
|
2007-12-10 |
2009-06-19 |
Novartis Ag |
Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias.
|
|
CA2716838C
(en)
*
|
2008-02-29 |
2014-01-07 |
Schering Corporation |
Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
WO2009128947A1
(en)
*
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
CA2727196A1
(en)
|
2008-06-10 |
2009-12-17 |
Novartis Ag |
Organic compounds
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
CN102256963B
(zh)
|
2008-12-19 |
2014-06-11 |
贝林格尔.英格海姆国际有限公司 |
作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
|
|
PL2391366T3
(pl)
|
2009-01-29 |
2013-04-30 |
Novartis Ag |
Podstawione benzimidazole do leczenia gwiaździaków
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
EA201200260A1
(ru)
|
2009-08-12 |
2012-09-28 |
Новартис Аг |
Гетероциклические гидразоны и их применение для лечения рака и воспаления
|
|
NZ598220A
(en)
|
2009-08-17 |
2014-02-28 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
CA2771432A1
(en)
|
2009-08-20 |
2011-02-24 |
Novartis Ag |
Heterocyclic oxime compounds
|
|
US20110098311A1
(en)
|
2009-10-22 |
2011-04-28 |
Vertex Pharmaceuticals Incorported |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
|
EP2513086B1
(en)
*
|
2009-12-17 |
2015-04-29 |
Boehringer Ingelheim International GmbH |
Novel antagonists for ccr2 and uses thereof
|
|
ES2674275T3
(es)
|
2009-12-17 |
2018-06-28 |
Centrexion Therapeutics Corporation |
Antagonistas del receptor CCR2 y usos de los mismos
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
WO2011141474A1
(en)
|
2010-05-12 |
2011-11-17 |
Boehringer Ingelheim International Gmbh |
Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
|
|
JP5646736B2
(ja)
|
2010-05-12 |
2014-12-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
|
|
WO2011144501A1
(en)
|
2010-05-17 |
2011-11-24 |
Boehringer Ingelheim International Gmbh |
Ccr2 antagonists and uses thereof
|
|
WO2011147772A1
(en)
|
2010-05-25 |
2011-12-01 |
Boehringer Ingelheim International Gmbh |
Ccr2 receptor antagonists
|
|
US8962656B2
(en)
|
2010-06-01 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
CCR2 antagonists
|
|
PT2593452T
(pt)
|
2010-07-14 |
2017-04-24 |
Novartis Ag |
Compostos heterocíclicos agonistas do receptor ip
|
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
|
EP2673277A1
(en)
|
2011-02-10 |
2013-12-18 |
Novartis AG |
[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
EP2731941B1
(en)
|
2011-07-15 |
2019-05-08 |
Boehringer Ingelheim International GmbH |
Novel and selective ccr2 antagonists
|
|
WO2013024022A1
(en)
|
2011-08-12 |
2013-02-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for treatment of pulmonary hypertension
|
|
US8883819B2
(en)
|
2011-09-01 |
2014-11-11 |
Irm Llc |
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
|
|
CA2848809A1
(en)
|
2011-09-15 |
2013-03-21 |
Novartis Ag |
6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase
|
|
WO2013038386A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Heterocyclic compounds for the treatment of cystic fibrosis
|
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
|
ES2882807T3
(es)
|
2011-09-16 |
2021-12-02 |
Novartis Ag |
Heterociclil carboxamidas N-sustituidas
|
|
JP6130391B2
(ja)
|
2011-11-23 |
2017-05-17 |
インテリカイン， エルエルシー |
Ｍｔｏｒ阻害剤を使用する強化された治療レジメン
|
|
US20140357641A1
(en)
|
2012-01-13 |
2014-12-04 |
Novartis Ag |
IP receptor agonist heterocyclic compounds
|
|
US9115129B2
(en)
|
2012-01-13 |
2015-08-25 |
Novartis Ag |
Substituted pyrido[2,3-B]pyrazines as IP receptor agonists
|
|
US9174985B2
(en)
|
2012-01-13 |
2015-11-03 |
Novartis Ag |
Salts of 7-(2,3-di-p-tolyl-7,8-dihydropyrido[2,3-b]pyrazin-5(6H)-yl)heptanoic acid as IP receptor agonists
|
|
UY34572A
(es)
|
2012-01-13 |
2013-09-02 |
Novartis Ag |
Compuestos heterocíclicos agonistas del receptor ip
|
|
WO2013105058A1
(en)
|
2012-01-13 |
2013-07-18 |
Novartis Ag |
7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
|
|
US20150005311A1
(en)
|
2012-01-13 |
2015-01-01 |
Novartis Ag |
IP receptor agonist heterocyclic compounds
|
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
|
AU2013243097A1
(en)
|
2012-04-03 |
2014-10-09 |
Novartis Ag |
Combination products with tyrosine kinase inhibitors and their use
|
|
EP2912047B1
(en)
|
2012-10-29 |
2016-08-24 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
CN105189500A
(zh)
|
2013-02-13 |
2015-12-23 |
诺华股份有限公司 |
Ip受体激动剂杂环化合物
|
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
|
EP2968340A4
(en)
|
2013-03-15 |
2016-08-10 |
Intellikine Llc |
COMBINING KINASE INHIBITORS AND USES THEREOF
|
|
TW201605450A
(zh)
|
2013-12-03 |
2016-02-16 |
諾華公司 |
Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
|
|
CA2945212A1
(en)
|
2014-04-24 |
2015-10-29 |
Novartis Ag |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
BR112016024484A2
(pt)
|
2014-04-24 |
2017-08-15 |
Novartis Ag |
derivados de aminopiridina como inibidores de fosfatidilinositol 3-quinase
|
|
US9862711B2
(en)
|
2014-04-24 |
2018-01-09 |
Novartis Ag |
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
|
CA2954862A1
(en)
|
2014-07-31 |
2016-02-04 |
Novartis Ag |
Combination therapy
|
|
JP6633618B2
(ja)
*
|
2014-08-21 |
2020-01-22 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
強力なｒｏｃｋ阻害剤としてのタイドバックのベンズアミド誘導体
|
|
PT3317270T
(pt)
|
2015-07-02 |
2020-08-24 |
Centrexion Therapeutics Corp |
(4-((3r,4r)-3-metoxitetrahidro-pirano-4-ilamino)piperidina-1-il)(5-metil-6-(((2r,6s)-6-(p-tolil)tetrahidro-2h-pirano-2-il)metilamino)pirimidina-4-il)citrato de metanona
|
|
AU2020290094B2
(en)
|
2019-06-10 |
2024-01-18 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis
|
|
AU2020338971B2
(en)
|
2019-08-28 |
2023-11-23 |
Novartis Ag |
Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
US11629196B2
(en)
|
2020-04-27 |
2023-04-18 |
Incelldx, Inc. |
Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
|